Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program

por de Moura, Alexandre, Vuagnat, Perrine, Renouf, Benjamin, Pierga, Jean-Yves, Loirat, Delphine, Vaflard, Pauline, Lafayolle de la Bruyère, Charline, Chaumard-Billotey, Natacha, Hajjaji, Nawale, Ladoire, Sylvain, Dabakuyo, Sandrine, Patsouris, Anne, Frenel, Jean Sébastien, Nicolai, Vincent, Alexandre, Marie, Dohollou, Nadine, Grenier, Julien, Bourien, Heloïse, Bidard, François-Clément
Publicado 2023

Efficacy of taxanes rechallenge in first-line treatment of early metastatic relapse of patients with HER2-negative breast cancer previously treated with a (neo)adjuvant taxanes reg...

por Vasseur, Antoine, Carton, Matthieu, Guiu, Severine, Augereau, Paule, Uwer, Lionel, Mouret-Reynier, Marie-Ange, Levy, Christelle, Eymard, Jean-Christophe, Ferrero, Jean-Marc, Leheurteur, Marianne, Goncalves, Anthony, Robert, Marie, De La Motte Rouge, Thibault, Bachelot, Thomas, Petit, Thierry, Debled, Marc, Grinda, Thomas, Desmoulins, Isabelle, Vanlemmens, Laurence, Nicolaï, Vincent, Simon, Gaëtane, Cabel, Luc
Publicado 2022